Abstract
Aim: To evaluate ovarian function after modern intensive multi-agent chemotherapy for osteosarcoma given during childhood or adolescence.
Methods: After discontinuation of treatment, 10 female osteosarcoma survivors were followed up for 1.5–14 (median 4.6) years. Their age at diagnosis was a median of 12.9 (range 6–15) years and at the last follow up 18.6 (range 16–22). The main follow up included recording of their pubertal and menstrual status and of sex hormone determinations.
Results: Prior to diagnosis, 5/10 had had their menarche, and one had it while on therapy. At discontinuation of chemotherapy, ovarian function had severely deteriorated; none of the girls experienced regular menstrual cycles. However, during follow up, significant restoration of ovarian function was evident. At the last follow up, 9/10 patients were menstruating spontaneously. During follow up, four patients, three of whom had received high doses of alkylating agents, presented with clear hypergonadotrophism with high FSH levels (14.4–132 IU/l). Three of these four patients initiated menstruation after their gonadotrophin levels normalised.
Conclusions: The modern multi-agent chemotherapy applied for osteosarcoma impairs ovarian function. Normalisation of ovarian function is common, even in cases with severe hypergonadotrophic hypogonadism, but may only occur after several years off chemotherapy. Regular assessment of ovarian function and cautious use of hormone replacement therapy are important in patients with chemotherapy induced gonadal damage.
Full Text
The Full Text of this article is available as a PDF (79.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bacci G., Ferrari S., Bertoni F., Ruggieri P., Picci P., Longhi A., Casadei R., Fabbri N., Forni C., Versari M. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000 Dec 15;18(24):4016–4027. doi: 10.1200/JCO.2000.18.24.4016. [DOI] [PubMed] [Google Scholar]
- Bath L. E., Anderson R. A., Critchley H. O., Kelnar C. J., Wallace W. H. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod. 2001 Sep;16(9):1838–1844. doi: 10.1093/humrep/16.9.1838. [DOI] [PubMed] [Google Scholar]
- Byrne J., Fears T. R., Gail M. H., Pee D., Connelly R. R., Austin D. F., Holmes G. F., Holmes F. F., Latourette H. B., Meigs J. W. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992 Mar;166(3):788–793. doi: 10.1016/0002-9378(92)91335-8. [DOI] [PubMed] [Google Scholar]
- Byrne J., Mulvihill J. J., Myers M. H., Connelly R. R., Naughton M. D., Krauss M. R., Steinhorn S. C., Hassinger D. D., Austin D. F., Bragg K. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med. 1987 Nov 19;317(21):1315–1321. doi: 10.1056/NEJM198711193172104. [DOI] [PubMed] [Google Scholar]
- Dunkel L., Alfthan H., Stenman U. H., Perheentupa J. Gonadal control of pulsatile secretion of luteinizing hormone and follicle-stimulating hormone in prepubertal boys evaluated by ultrasensitive time-resolved immunofluorometric assays. J Clin Endocrinol Metab. 1990 Jan;70(1):107–114. doi: 10.1210/jcem-70-1-107. [DOI] [PubMed] [Google Scholar]
- Hammond G. L., Viinikka L., Vihko R. Automation of radioimmunoassays for some sex steroids with use of both iodinated and tritiated ligands. Clin Chem. 1977 Jul;23(7):1250–1257. [PubMed] [Google Scholar]
- Himelstein-Braw R., Peters H., Faber M. Morphological study of the ovaries of leukaemic children. Br J Cancer. 1978 Jul;38(1):82–87. doi: 10.1038/bjc.1978.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Howell S., Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998 Dec;27(4):927–943. doi: 10.1016/s0889-8529(05)70048-7. [DOI] [PubMed] [Google Scholar]
- Longhi A., Porcu E., Petracchi S., Versari M., Conticini L., Bacci G. Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity. Cancer. 2000 Nov 1;89(9):1961–1965. doi: 10.1002/1097-0142(20001101)89:9<1961::aid-cncr12>3.3.co;2-#. [DOI] [PubMed] [Google Scholar]
- Matsumoto M., Shinohara O., Ishiguro H., Shimizu T., Hattori K., Ichikawa M., Yabe H., Kubota C., Yabe M., Kato S. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child. 1999 May;80(5):452–454. doi: 10.1136/adc.80.5.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nasir J., Walton C., Lindow S. W., Masson E. A. Spontaneous recovery of chemotherapy-induced primary ovarian failure: implications for management. Clin Endocrinol (Oxf) 1997 Feb;46(2):217–219. doi: 10.1046/j.1365-2265.1997.771575.x. [DOI] [PubMed] [Google Scholar]
- Nicholson H. S., Mulvihill J. J., Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol. 1992;20(1):6–12. doi: 10.1002/mpo.2950200103. [DOI] [PubMed] [Google Scholar]
- Nicosia S. V., Matus-Ridley M., Meadows A. T. Gonadal effects of cancer therapy in girls. Cancer. 1985 May 15;55(10):2364–2372. doi: 10.1002/1097-0142(19850515)55:10<2364::aid-cncr2820551011>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Provisor A. J., Ettinger L. J., Nachman J. B., Krailo M. D., Makley J. T., Yunis E. J., Huvos A. G., Betcher D. L., Baum E. S., Kisker C. T. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997 Jan;15(1):76–84. doi: 10.1200/JCO.1997.15.1.76. [DOI] [PubMed] [Google Scholar]
- Rosen G., Caparros B., Groshen S., Nirenberg A., Cacavio A., Marcove R. C., Lane J. M., Huvos A. G. Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors. Cancer Invest. 1984;2(3):181–192. doi: 10.3109/07357908409104370. [DOI] [PubMed] [Google Scholar]
- Sanders J. E., Buckner C. D., Amos D., Levy W., Appelbaum F. R., Doney K., Storb R., Sullivan K. M., Witherspoon R. P., Thomas E. D. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol. 1988 May;6(5):813–818. doi: 10.1200/JCO.1988.6.5.813. [DOI] [PubMed] [Google Scholar]
- Sarafoglou K., Boulad F., Gillio A., Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997 Feb;130(2):210–216. doi: 10.1016/s0022-3476(97)70345-7. [DOI] [PubMed] [Google Scholar]
- Sklar C. A. Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatr Suppl. 1999 Dec;88(433):1–4. doi: 10.1111/j.1651-2227.1999.tb14395.x. [DOI] [PubMed] [Google Scholar]
- Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol. 1999 Jul;33(1):2–8. doi: 10.1002/(sici)1096-911x(199907)33:1<2::aid-mpo2>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
- Uchida A., Myoui A., Araki N., Yoshikawa H., Shinto Y., Ueda T. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer. 1997 Jan 15;79(2):411–415. [PubMed] [Google Scholar]
- Wallace W. H., Shalet S. M., Crowne E. C., Morris-Jones P. H., Gattamaneni H. R., Price D. A. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol. 1989;17(5):409–413. doi: 10.1002/mpo.2950170510. [DOI] [PubMed] [Google Scholar]
- Warne G. L., Fairley K. F., Hobbs J. B., Martin F. I. Cyclophosphamide-induced ovarian failure. N Engl J Med. 1973 Nov 29;289(22):1159–1162. doi: 10.1056/NEJM197311292892202. [DOI] [PubMed] [Google Scholar]